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Synthesis and antimicrobial study of N-[4-(2-
piperidine-1-yl-ethoxy) phenyl] acetamide analogues 
 
 
H. P. Jayadevappa, G. Nagendrappa, S. Umesha and S. Chandrashekar 
 
ABSTRACT  
 
 In the present study, a novel series of N-[4-(2-piperidine-1-yl-ethoxy) phenyl]-
acetamides were synthesized from 4-aminophenol and characterised by IR, 1H-NMR, Mass 
spectral studies and elemental analysis. The  antimicrobial potency of compounds is tested against 
variety of  fungal and bacterial strains by disc agar diffusion technique. in comparison to to 
fluconazole  and chloramphenicol respectively. Some of the synthesized compounds exhibit the 
potency  comparable  to that of standard drugs. 
 
 
Keywords: N-[4-(2-piperidine-1-yl-ethoxy)phenyl]-acetamide; Synthetic sequence; 
Antimicrobial study; Disc agar diffusion technique 
 
 INTRODUCTION 
 
 Today the design of new molecules and study of their biological potency is very 
important target. The synthesis new antimicrobial agents with reduced toxicity and lower side 
effect is a continuous process to combat antimicrobial resistance (Lewis 1985; Vanessa et al., 
2011). As the microorganisms are becoming resistant more quickly than new drugs are being made 
available, the feature research in antimicrobial therapy is to overcome resistance to antimicrobials 
or how to treat infections with alternate means such as species specific phages (Molecular 
mechanisms, 1994; Neu, 1996). The acetamide moiety is a core structure in various synthetic 
pharmaceuticals displaying a broad spectrum of biological activity including antimicrobial, 
antioxidant, anti-inflammatory, tranquilizer and antagonist properties (Jian Jeffrey Chen, 2008; 
Olgen and Bakar,  2011; Cappelli,  2011; Huma Jawed, 2010; Kanagarajan, 2010). Introduction of 
acetamide moiety on certain drugs found to enhance their pharmacological property on respiratory 
tract Pathogens(Nomura, 2006). Recently mechanism of inhibition of the enzyme HIV-1 reverse 
transcriptas by certain  thienyl acetamide derivatis were performed(Herschhorn, 2008). The 
potency of piperidine analogues as chemotherapeutic agents, in particular antibacterial and 
antifungal agents are well documented. The analogous were found to exhibit efficient antimalarial, 
anticancer and anti HIV activities (Harper, 2005; Sahoo,  2010; Venkatachalam, 2000). Scientists 
studied relationship between structure and biological activity of derivatives of piperidine (Komoto, 
2000). Piperidino-acetamides posses excellent  anxiolytic, analgesic, sedative, antiepileptic and 
antagonist properties (Naya,  2001; Kenda,  2004; Palin,  2007; Rezvani,  2007). Based on this 
information it was considered valuable to synthesize a new class of piperidino acetamides and to 
study their antimicrobial proficiency. 
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MATERIAL AND METHODS 
 
Synthetic sequence 
 Chemicals used were of analar grade. The reactions were 
monitored by TLC on aluminium-backed silica plate visualized by 
UV-light. Melting points were determined on a Thomas Hoover 
capillary melting point apparatus using digital thermometer. 1H 
NMR spectra were recorded on a Bruker 300 MHz spectrometer in 
CDCl3. Chemical shifts were recorded in parts per million down 
field from tetramethyl silane. Mass spectra were recorded on a 
VG70-70H mass spectrometer. 
    
I. Synthesis of N-(4-hydroxyphenyl)acetamides 
 The synthetic sequence is out lined in scheme-1. A 
mixture of 4-aminophenol (1.10 mmol) and corresponding 
carboxylic acid (2a-e. 10 mmol) in few ml of water and few drops 
of pyridine catalyst was stirred for 24 hours at room temperature. 
The product was extracted with ice cold ether (3x40 ml). The ether 
layer was washed with 2% sodium carbonate solution (3x20 ml), 
2% hydrochloric acid solution (3x30 ml) and distilled water. Then 
the organic layer was dried over anhydrous sodium sulfate and 
evaporated to dryness. The crude product was recrystallized using 
alcohol to afford N-(4-hydroxyphenyl)acetamides (3a-e). 
 
Charecterisation of compounds (3a-e) 
Compound 3a. N-(4-hydroxyphenyl)acetamide  
 mp 168-1700C; IR(Nujol) 1670cm-1 (amide, C=O), 
3395cm-1 (amide, N-H),  3515-3630cm-1   (O-H); 1H 
NMR(CDCl3); δ 2.47(s, 3H, CH3), 3.1(s distd , 1H, N-H), 6.9-
7.4(m, 4H, Ar-H), 9.0(br s, 1H, OH); EI-MS; m/z 152 (M+, 82), 
153 (M+, 72), 151 (100), 137 (65), 92 (35). Anal. Calcd for 
C8H9NO2 (151); C, 63.57; H, 6.00; N, 9.27. Found; C, 63.61; H, 
6.05; N, 9.31.  
 
Compound 3b. N-(4-hydroxyphenyl)-2-phenyl acetamide  
 mp 185-1870C; IR(Nujol) 1685cm-1 (amide, C=O), 
3420cm-1 (amide, N-H), 3520-3620cm-1    (O-H); 1H 
NMR(CDCl3); δ3.09(s distd, 1H, N-H), 6.8-7.6(m, 9H, Ar-H), 
9.0(br s, 1H, OH); EI-MS; m/z 227 (M+, 100), 226 (M+, 85), 228 
(M+,59), 137 (62), 92 (42), 90(71).  Ana. Calcd for C14H13NO2 
(227); C, 73.95; H, 5.78;  N, 6.17. Found; C, 74.02; H, 5.72; N, 
6.12.  
 
Compound 3c. N-(4-hydroxyphenyl)-2-(4- chlorophenyl)acetamide  
 mp 192-1940C; IR(Nujol) 1680cm-1 (amide, C=O), 
3375cm-1 (amide, N-H), 3515-3630cm-1      (O-H); 1H 
NMR(CDCl3); δ  3.08(s distd , 1H, N-H), 6.9-7.5(m, 8H, Ar-H), 
9.0(br s, 1H, OH); EI-MS; m/z 262.5 (M+, 73), 261.5 (M+, 95), 260 
(M+,45), 136 (63), 92 (35), 124.5(78). Anal. Calcd for 
C14H12ClNO2 (261.5); C, 64.22; H,  4.61; Cl, 13.54; N, 5.35. 
Found; C, 64.24; H, 4.57; Cl, 13.51; N, 5.38.  
 
Compound 3d. N-(4-hydroxyphenyl)-2-phenoxy acetamide  
 mp    178- 1800C;   IR  (Nujol)   1640 cm-1   (amide, C=O),  
3370cm-1 (amide, N-H), 3510-3625cm-1    (O-H); 1H 
NMR(CDCl3); δ 2.6(s, 2H, CH2), 3.0(s distd , 1H, N-H), 6.8-7.5(m, 
9H, Ar-H), 9.0(br s, 1H, OH); EI-MS; m/z 243 (M+, 89), 244 (M+, 
55), 242 (M+,78), 151 (92), 137(73). Anal. Calcd for C14H13NO3 
(243); C, 69.11; H, 5.39; N, 5.75. Found; C, 69.05; H, 5.41; N, 
5.79.  
 
Compound 3e. N- (4- hydroxyphenyl)- 2- (2, 4-dimethoxyphenyl) 
acetamide  
 mp 182-1840C; IR(Nujol) 1660cm-1 (amide, C=O), 
3380cm-1 (amide, N-H), 3510-3630cm-1 (O-H); 1H NMR(CDCl3); 
δ 2.5(s, 2H, Ar-CH2), 3.0(s distd , 1H, N-H), 3.8(s, 6H, OCH3), 
7.0-7.6(m, 7H, Ar-H), 9.0(br s, 1H, OH); EI-MS; m/z 288.4 (M+, 
72), 287.4 (M+, 83), 285.5 (M+,92), 137 (89), 151(35). Anal. Calcd 
for C16H17NO4  (287); C,  66.85; H, 5.94; N, 4.86. Found; C, 66.77; 
H, 5.97; N, 4.85.  
 
II. Synthesis of N-[4-(2-piperidine-1-yl-ethoxy)phenyl]acetamides 
 A mixture of 3a-e (2 mmol) and 1-(2-
chloroethyl)piperidine hydrochloride (2 mmol) in presence of 
anhydrous potassium carbonate (5 mmol) and dimethyl sulfoxide 
(15 ml) was refluxed for 10 hours and then cooled. The residual 
mass was triturated with ice water to remove potassium carbonate 
and dimethyl sulfoxide. Then the product was extrated with 
chloroform (3x20 ml).  The organic layer was washed with 
saturated sodium chloride solution (3x20 ml) and   2% sodium 
hydroxide solution (3x20 ml) followed by distilled water and dried 
over anhydrous sodium sulfate. The crude product obtained by the 
evaporation of organic layer on recrystallizaton using ethanol 
affords pasty mass of title compounds N-[4-(2-piperidine-1-yl-
ethoxy)phenyl]acetamides (4a-e). The compounds 3a-e and 4a-e 
were   characterized by IR, 1H-NMR,  Mass spectral studies and 
elemental analysis.  
 
Compound 4a. N-[4-(2-piperidine-1-yl-ethoxy)phenyl]acetamide 
 Pasty mass mp 182-1840C; IR(Nujol) 1678cm-1 (amide, 
C=O), 3390cm-1  (amide, N-H); 1H NMR(CDCl3); δ 1.043(m, 6H, 
ring 3CH2), 1.203(t, 4H, ring 2N-CH2), 2.0(t, 2H, N-CH2), 2.474(s, 
3H, CH3), 3.0(s distd , 1H, N-H), 3.8(t, 2H, O-CH2), 7.0-7.6(m, 
4H, Ar-H); EI-MS; m/z 264 (M+, 65), 263 (M+, 78), 112 (M+, 95), 
Anal.  Calcd for C15H22N2O2 (262); C, 68.67; H, 8.44; N, 10.65. 
Found; C, 68.70; H, 8,42; N, 10.71.  
 
Compound 4b. N-[4-(2-piperidine-1-yl-ethoxy)phenyl]-2-phenyl 
acetamide  
 Pasty mass mp 190-1920C; IR(Nujol) 1682cm-1 (amide, 
C=O), 3425cm-1  (amide, N-H); 1H NMR(CDCl3); δ 1.040(m, 6H, 
ring 3CH2),1.20(t, 4H, ring 2N-CH2), 2.02(t, 2H, N-CH2), 3.0(s 
distd , 1H, N-H), 3.8(t, 2H, O-CH2), 6,8-7.8(m, 9H, Ar-H); EI-MS; 
m/z 339 (M+, 91), 338 (M+, 85), 113 (93), Anal.  Calcd for 
C21H26N2O2 (338); C, 74.5; H, 7,73;  N, 8.26. Found; C, 73.8; H, 
7.72; N, 8.23.  
 
Compound 4c. . N-[4-(2-piperidine-1-yl-ethoxy)phenyl]-2-(4- 
chlorophenyl)acetamide  
 Pasty mass mp 188-1900C; IR(Nujol) 1685cm-1 (amide, 
C=O), 3490cm-1 (amide, N-H); 1H NMR(CDCl3); δ 1.05(m, 6H,  
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ring 3CH2),1.22(t, 4H, ring 2N-CH2), 2.02(t, 2H, N-CH2), 3.0(s 
distd , 1H, N-H), 3.8(t, 2H, O-CH2), 6,9-7.8(m, 8H, Ar-H); EI-MS; 
m/z 373 (M+, 93), 372 (M+, 84), 374 (M+, 82), 112 (89), Anal.  
Calcd for C21H25ClN2O2 (372.5); C, 67.58; H, 6.74; Cl, 9.48; N, 
7.48. Found; C, 67.55; H, 6.75; Cl, 9.5; N, 7.47.  
 
Compound 4d. N-[4-(2-piperidine-1-yl-ethoxy)phenyl]-2-phenoxy 
acetamide  
 Pasty mass mp 184-1860C; IR(Nujol) 1620cm-1 (amide, 
C=O), 3440cm-1 (amide, N-H); 1H NMR(CDCl3); δ 1.03(m, 6H, 
ring 3CH2), 1.2(t, 4H, ring 2N-CH2), 2.0(t, 2H, N-CH2), 2.6(s, 2H, 
CH2), 3.05(s distd , 1H, N-H), 3.8(t, 2H, O-CH2), 6.9- 7.8(m, 9H, 
Ar-H); EI-MS; m/z 356.5 (M+, 85), 357.5 (M+, 69), 355 (M+, 72), 
113 (72), Anal.  Calcd for C21H26N2O3 (354); C, 70.9; H, 7.35;  N, 
7.88. Found; C, 71.14; H, 7.33; N, 7.85.  
 
Compound 4e. N-[4-(2-piperidine-1-yl-ethoxy)phenyl]-2-(2,4-
dimethoxyphenyl)acetamide  
 Pasty mass mp 176-1780C; IR(Nujol) 1665cm-1 (amide, 
C=O), 3400cm-1  (amide, N-H); 1H NMR(CDCl3); δ 1.1(m, 6H, 
ring 3CH2), 1.24(t, 4H, ring 2N-CH2), 2.02(t, 2H, N-CH2), 2.5(s, 
2H, Ar-CH2), 3.08(s distd , 1H, N-H), 3.2(t, 2H, O-CH2), 3.8(s, 
6H, OCH3), 6.9- 7.8(m, 7H, Ar-H); EI-MS; m/z 400 (M+, 76), 401 
(M+, 62), 399 (M+, 90), 112.3 (68),  Anal.  Calcd for  C23H30N2O4 
(398); C, 69.21; H, 7.54;  N, 6.95. Found; C, 69.3; H, 7.55; N, 
6.98.  
 
Antimicrobial study  
 The compounds 1, 3a-e, 4a-e and piperidine were 
screened for antifungal and antibacterial activity by disc agar 
diffusion technique at different concentrations ranging from 25 to 
250 micro g/mL in ethylacetate (Bauer. A. W 1966). The specific 
bacterial culture was spread uniformly over nutrient agar in Petri 
plates. Then the test solution, standard and control of known 
similar concentration were spotted in sample wells at specific 
distance. The zones of inhibition were measured after 24 hour 
incubation at 370c for antibacterial activity and 48 hour incubation 
at 250c for antifungal activity (Barry; 1979). The inhibitory 
concentration of 50 micro g/mL, was selected and the experiments 
were carried out induplicate repeatedly to get reproducible results.   
 
RESULT AND DISCUSSION 
 
Antifungal activity  
 The in vitro antifungal activity of compounds were 
evaluated against the fungi F.oxysporum, A.flavus, C.capsici and 
C.krusei ausing  fluconazole as the reference standard and the 
results are summarized in table-1. The synthesized acetamides 3a-e 
possess enhanced activity when compared piperidine and the 
compound 4-aminophenol which is the core structure in the series. 
The efficacy of title compounds 4a-e is comparable with that of 
standard drug fluconazole. The screening results reveal that the 
activity of compound 4a, a simple acetamide is nearly same as that 
 
 
 of standard to all the four fungi. The compound 4b with benzyl 
group attached to acetamide linkage is more potent to F.oxysporum 
but less potent to the other three fungi. It is worth to notice that 
compound 4c with chlorine on C4 of aromatic ring  is more potent 
than the standard fluconazole against A.flavus, equipotent against 
C.copsici and slightly less potent against F.oxysporum and 
C.krusei. The compounds 4d and 4e with phenoxy methyl group 
and 2,4-dimethxy benzyl group are more potent than the standard 
against A.flavus and  C.capsici where as less potent against 
F.oxysporum and C.krusei.  
 
Table. 1: Antifungal screening results of compounds 3a-e and 4a-e at concentration 
50 µg/ml  Zone of inhibition in mm.  
 
Compound F.oxysporum A.flavus C.capsici C.krusei 
3a 
3b 
3c 
3d 
3e 
4a 
4b 
4c 
4d 
4e 
Control 
1 
Piperidine 
Fluconazole 
2.0 
3.5 
2.5 
2.0 
2.0 
7.5 
9.5 
6.0 
6.5 
6.5 
- 
1.0 
1.5 
8.5 
2.0 
3.0 
3.5 
3.0 
3.5 
6.5 
6.0 
8.5 
8.0 
8.5 
- 
1.0 
1.5 
7.5 
2.5 
2.0 
2.5 
3.0 
3.0 
6.0 
4.5 
6.5 
7.5 
7.0 
- 
0.5 
1.0 
6.5 
2.0 
2.5 
2.0 
2.5 
2.5 
4.0 
4.0 
3.5 
4.0 
3.5 
- 
0.5 
1.0 
5.0 
 
Antibacterial activity  
 The results of in vitro antibacterial activity against the 
bacteria E.coli,   R.solanacearum   C.botulinum and B.subtilis  
using chloramphenicol as reference standard are summarized in 
table-2. Once again the synthesized acetamides 3a-e showed 
increased potency when compared to piperidine  and 4-
aminophenol and the efficacy of title compounds 4a-e is 
comparable with that of standard drug chloramphenicol. The 
compound 4a is marginally less potent to chloramphenicol for all 
the  bacteria. The compounds 4b and 4c are more potent than the 
standard against E.coli and  R.solanacearum. The enhanced activity 
may be due to the benzyl group and 4-chloro benzyl group bonded 
to amide carbon. The compounds 4d and 4e shows lesser efficacy.  
 
Table. 2: Antibacteerial screening results of compounds 3a-e and 4a-e at 
concentration 50 µg/ml Zone of inhibition in mm. 
 
Compound E.coli R.solanacearum   C. botulinum B.subtilis 
3a 
3b 
3c 
3d 
3e 
4a 
4b 
4c 
4d 
4e 
Control 
1 
Piperidine 
Chloramphe
nicol 
3.5 
4.5 
4.5 
3.5 
3.0 
7.5 
9.0 
9.5 
8.0 
8.5 
- 
1.0 
2.0 
8.0 
4.5 
5.0 
5.5 
4.5 
4.0 
8.5 
9.5 
9.5 
7.0 
6.5 
- 
1.5 
1.5 
9.0 
3.0 
3.5 
3.5 
2.5 
2.0 
5.0 
5.5 
6.0 
5.5 
5.5 
- 
0.5 
1.0 
6.0 
3.0 
3.0 
3.5 
3.5 
3.0 
6.0 
6.5 
7.5 
7.5 
7.0 
- 
1.0 
1.5 
7.5 
 
 
 
Journal of Applied Pharmaceutical Science 02 (03); 2012: 192-196 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 In conclusion the synthesized compounds were found to 
posses more antibacterial activity than antifungal activity 
compared to respective reference standards. . The antimicrobial 
potency of the compounds is more against gram negative bacteria 
compared to gram positive bacteria. The excellent potency of 
compound 4c with chlorine on aromatic ring indicates the 
importance of functional groups in enhancing the biological 
activity. Weaker efficacy was exhibited by all synthesized 
compounds against the bacteria C. botulinum and the fungus 
C.krusei with few exceptional cases. It is important to notice that 
the compounds 4d and 4e possessing phenoxy group and 
dimethoxy benzyl group were lesser active against all the bacteria 
and fungi with the exception of  F.oxysporum, C.krusei and E.coli. 
In view the significant activity of compounds can be exploited in 
the formulation of bactericides and fungicides.       
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